Scharf Investments Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$96.3M |
| 2 |
Johnson & Johnson
JNJ
|
+$58.2M |
| 3 |
Watsco Inc
WSO
|
+$34.4M |
| 4 |
Novartis
NVS
|
+$25.7M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$20.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CDK
CDK Global, Inc.
CDK
|
+$124M |
| 2 |
WBA
Walgreens Boots Alliance
WBA
|
+$61.3M |
| 3 |
Hershey
HSY
|
+$50.4M |
| 4 |
CERN
Cerner Corp
CERN
|
+$34.8M |
| 5 |
Microsoft
MSFT
|
+$12.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.41% |
| 2 | Healthcare | 18.43% |
| 3 | Financials | 13.64% |
| 4 | Communication Services | 12.17% |
| 5 | Consumer Discretionary | 11.83% |
Similar funds
Scharf Investments's Q2 2019 Portfolio in Review
As of Q2 2019, Scharf Investments held 47 positions worth $2.54B, down 2.2% from $2.59B the previous quarter. Its ten largest holdings account for 53% of the portfolio.
Scharf Investments withdrew a net $170M in Q2 2019, closing 11 positions and reducing 27 holdings. Its most notable exit was Mastercard, an estimated $3.59M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Scharf Investments opened a new position in State Street SPDR Bloomberg 1-3 Month T-Bill ETF worth $96.4M.
- Scharf Investments's largest Q2 2019 buy was State Street SPDR Bloomberg 1-3 Month T-Bill ETF: 1,051,801 shares worth $96.4M.
- Scharf Investments added most to Novartis in Q2 2019, an estimated $25.7M increase.
- Scharf Investments's biggest Q2 2019 reduction was CDK Global, Inc., cutting an estimated $124M.
- Scharf Investments fully exited Mastercard in Q2 2019, selling an estimated $3.59M.
- Scharf Investments's ten largest holdings make up 53% of its $2.54B portfolio in Q2 2019.
- Scharf Investments opened 4 new positions and closed 11 in Q2 2019.
- Scharf Investments's portfolio value fell 2.2% quarter-over-quarter to $2.54B.
Based on Scharf Investments's 13F filing for Q2 2019, filed 13 Aug 2019.